Related Experiment Video
Updated: Sep 8, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Fanconi anemia cells have a normal gene structure for topoisomerase I
H Saito1, M Grompe, T L Neeley
1Department of Molecular and Medical Genetics, Oregon Health Sciences University, Portland 97201.
Abstract:
Cells from Fanconi anemia (FA) patients have defective DNA repair and are hypersensitive to DNA crosslinking agents such as mitomycin C (MMC). We examined the possibility that topoisomerase I is involved in the DNA crosslink repair system and is deficient in FA group A cells. FA cells and control cells were exposed to MMC with or without camptothecin (CPT), a topoisomerase I inhibitor. The cells did not show any increased sensitivity to killing by MMC with CPT, suggesting that the topoisomerase I is not involved in MMC-damaged DNA repair. However, FA cells showed increased sensitivity to CPT in comparison to control cells, raising the possibility of altered topoisomerase I in FA cells. Therefore, a mutation analysis was performed on topoisomerase I cDNA from FA cells by using chemical cleavage mismatch scanning and nucleotide sequencing. No mutation was detected from GM1309, a group A FA cell line. A base transition (C to T) at position 241, causing an amino acid change (His to Tyr), was found in GM2061, a FA cell line of unknown complementation group. However, allele-specific oligonucleotide hybridization analysis showed that this is a gene polymorphism. We conclude that FA cells have normal gene structure for topoisomerase I.
Insights
Fanconi anemia (FA) cells, which have DNA repair defects, were studied for topoisomerase I involvement in DNA crosslink repair. FA cells showed normal topoisomerase I gene structure, indicating it is not deficient in these patients.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Fanconi anemia (FA) is a genetic disorder characterized by defective DNA repair mechanisms.
- FA cells exhibit hypersensitivity to DNA crosslinking agents like mitomycin C (MMC).
- The role of topoisomerase I in DNA crosslink repair and its potential deficiency in FA cells remained unclear.
Purpose of the Study:
- To investigate the involvement of topoisomerase I in the DNA crosslink repair system.
- To determine if topoisomerase I is deficient in Fanconi anemia group A cells.
- To analyze the topoisomerase I gene structure in FA cells.
Main Methods:
- Exposure of FA and control cells to mitomycin C (MMC) with or without camptothecin (CPT), a topoisomerase I inhibitor.
- Assessment of cellular sensitivity to MMC and CPT treatments.
- Mutation analysis of topoisomerase I cDNA from FA cells using chemical cleavage mismatch scanning and nucleotide sequencing.
- Allele-specific oligonucleotide hybridization to identify gene polymorphisms.
Main Results:
- FA cells did not show increased sensitivity to combined MMC and CPT treatment, suggesting topoisomerase I is not involved in MMC-induced DNA crosslink repair.
- FA cells exhibited increased sensitivity to CPT alone compared to control cells.
- Mutation analysis revealed no mutations in topoisomerase I cDNA from a group A FA cell line (GM1309).
- A C-to-T transition (His to Tyr) found in another FA cell line (GM2061) was identified as a common gene polymorphism.
Conclusions:
- Topoisomerase I does not appear to be involved in the repair of DNA crosslinks induced by mitomycin C.
- Fanconi anemia cells possess a normal gene structure for topoisomerase I.
- The increased sensitivity of FA cells to camptothecin may be due to other factors, not a deficiency or mutation in topoisomerase I.
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. Type I...
Restarting Stalled Replication Forks
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
ATP Synthase: Mechanism
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

